Antidotes for factor Xa inhibitors and methods of using the same
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 9, 2020
Grant Date -
Dec 8, 2016
app pub date -
Jun 8, 2016
filing date -
Sep 28, 2007
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates antidotes to anticoagulants targeting factor Xa. The antidotes are factor Xa protein derivatives that bind to the factor Xa inhibitors thereby substantially neutralizing them but do not assemble into the prothrombinase complex. The derivatives describe herein lack or have reduced intrinsic coagulant activity. Disclosed herein are methods of stopping or preventing bleeding in a patient that is currently undergoing anticoagulant therapy with a factor Xa inhibitor.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully